Vasodilators..
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D001919:Bradycardia / Q000139:chemically induced; D001982:Bronchial Diseases / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy; D003704:Dementia / Q000188:drug therapy / Q000209:etiology; D004088:Dihydroergotoxine / Q000627:therapeutic use; D005021:Ethylamines / Q000627:therapeutic use; D005663:Furans / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007273:Injections, Intramuscular / Q000009:adverse effects; D007275:Injections, Intravenous; D013948:Moxisylyte / Q000627:therapeutic use; D009281:Naphthalenes / Q000627:therapeutic use; D009566:Nitrates / Q000627:therapeutic use; D010096:Oxprenolol / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011217:Practolol / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D005021:Ethylamines; D005663:Furans; D009281:Naphthalenes; D009566:Nitrates; D011422:Propionates; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D004088:Dihydroergotoxine; D000628:Aminophylline; D010096:Oxprenolol; D011433:Propranolol; D013948:Moxisylyte; D011217:Practolol